How to tailor your global market access strategy to local needs
Breaking down your global market access strategy to local needs and expectations - made easy.
Make sure to read the whole article on the topic!
Brought to you by Executive Insight
How to tailor your global market access strategy to local needs
Why do most pharma companies fail to localize their global market access approach?
- Late delivery
- Tools too complex
- Misalignment with local needs
How can we improve?
By acting on challenges that arise during the 5 phases of development and deployment of Market Access tools:
- Design
- Build
- Deploy
- Use
- Maintain and evolve
What are best practices in the "Design" and "Build" phases?
- Allocation of affiliate resources early on
- Collaboration with clinical development
- Validation cycles with physicians and payers
What are best practices in the "Deploy" and "Use" phases?
- Creation of guidance documents
- Advanced trainings for affiliates - simulations with real payers
- Alignment of local KPIs and incentives schemes
- Re-thinking of customer-facing teams
What are best practices in the "Maintain and Evolve" phase?
- Think program development, not tool development
- Create adaptable tools and improve them constantly
Finally, global organizations can bring real value to local affiliates through:
- Coordination and aggregation of information
- Transfer of best practice
- Repository of all evidence
- Harmonization across products and markets
=> Ask us about the methods to assess which challenge you should focus on to improve the adoption of Market Access tools locally!
